Real-life experience of lusutrombopag for cirrhotic patients with low platelet counts being prepared for invasive procedures

BACKGROUND AND AIMS: The present study aimed to report our real-life experience of the TPO receptor agonist lusutrombopag for cirrhotic patients with low platelet counts. METHODS: We studied platelet counts in 1,760 cirrhotic patients undergoing invasive procedures at our hospital between January 20...

Descripción completa

Detalles Bibliográficos
Autores principales: Takada, Hitomi, Kurosaki, Masayuki, Nakanishi, Hiroyuki, Takahashi, Yuka, Itakura, Jun, Tsuchiya, Kaoru, Yasui, Yutaka, Tamaki, Nobuharu, Takaura, Kenta, Komiyama, Yasuyuki, Higuchi, Mayu, Kubota, Youhei, Wang, Wann, Okada, Mao, Shimizu, Takao, Watakabe, Keiya, Enomoto, Nobuyuki, Izumi, Namiki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377090/
https://www.ncbi.nlm.nih.gov/pubmed/30768601
http://dx.doi.org/10.1371/journal.pone.0211122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377090/
https://www.ncbi.nlm.nih.gov/pubmed/30768601
http://dx.doi.org/10.1371/journal.pone.0211122

Ejemplares similares